Epidemiology of hypertension in serbia: Results of a national survey

Journal of Epidemiology

Volumn 22, Issue 3, 2012, Pages 261-266

  Vera Prof , Grujić ^a   Nataša, Dragnić ^a   Svetlana, Kvrgić ^a   Sonja, Šušnjević ^a   Jasmina, Grujić ^b   Sonja, Travar ^a  

^a INSTITUTE OF PUBLIC HEALTH OF VOJVODINA   (Serbia)

^b Institute for Transfusion   (Serbia)

Author keywords

Adult population; Hypertension; Serbia

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MALE; MIDDLE AGED; PREVALENCE; SERBIA;

ADULT; AGED; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; SERBIA; YOUNG ADULT;

EID: 84865830485     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20110077     Document Type: Article

References (45)

1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363-9.
2. Keys A. Seven countries: A multivariate analysis of death and coronary heart diseases. Cambridge, Massachusetts: Harvard University Press; 1980.
3. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence and control. Annu Rev Public Health.2006;27:465-90.
4. Whelton PK. Epidemiology of hypertension. Lancet. 1994;344:101-6.
5. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993;153(5):598-615.
6. Kannel WB. Blood pressure as a cardiovascular risk factor:prevention and treatment. JAMA. 1996;275(20):1571-6.
7. World Health Organization. World Health Report 2002. Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization; 2002.
8. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global regional burden of disease. Lancet.2002;360:1347-60.
9. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25(3):305-13.
10. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153(5):578-81.
11. Mellen PB, Goff DC. Non-pharmacological treatment of hypertension: Impact on prevalence estimates. Hypertension. 2007;50:e1.
12. Kaplan NM. Non-pharmacological treatment of hypertension. Proc Nutr Soc. 1987;46:373-7.
13. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V).Arch Intern Med. 1993;153(2):154-83.
14. Balazovjech I, Hnilica P Jr. Compliance with antihypertensive treatment in consultation rooms for hypertensive patients. J Hum Hypertens. 1993;7(6):581-3.
15. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001;38(4):809-14.
16. Grujić V. Health status, health needs and utilization of health care of population in Serbia. Glasnik Instituta za zaštitu zdravlja Srbije. 2002;76(1-2):26-147 (in Serbian).
17. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21(6):1011-53.
18. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17(2):151-83.
19. National Heart Lung and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7).The Guidelines. [cited 2011 Sep 20] Available from: http://www.nhlbi.nih.gov/guidelines/hypertension.
20. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26(1):60-9.
21. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
22. Erem C, Hacihasanoglu A, Kocak M, Deger O, Topbas M. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabson hypertension study.J Public Health (Oxf). 2008;31(1):47-58.
23. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11-9.
24. Chockalingam A, Campbell NR, Fodor G. Worldwide epidemic of hypertension. Can J Cardiol. 2006;22(7):553-5.
25. Banegas JR, Rodríguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillón P, Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998;32(6):998-1002.
26. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens. 1998;16(6):747-52.
27. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: Results from the Health Survey for England 1998. Hypertension. 2001;38:827-32.
28. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997;10:1097-102.
29. Minh HV, Byass P, Chuc NT, Wall S. Gender differences in prevalence and socioeconomic determinants of hypertension: findings from the WHO STEPs survey in a rural community ofVietnam. J Hum Hypertens. 2006;20(2):109-15.
30. Asmar R, Vol S, Pannier B, Brisac AM, Tichet J, El Hasnaoui A. High blood pressure and associated cardiovascular risk factors in France. J Hypertens. 2001;19(10):1727-32.
31. Public Health Agency of Canada. Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada, 2010. Adults with Diagnosed Hypertension (Prevalence).[cited 2011 Sep 20] Available from: http://www.phac-aspc.gc.ca/cd-mc/cvd-mcv/ccdss-snsmc-2010/2-2-eng.php.
32. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertensions: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
33. Sairenchi T, Irie F, Izumi Y, Muto T. Age-stratified analysis of the impact of hypertension on National Health Insurance Medical Expenditures in Ibaraki, Japan. J Epidemiol. 2010;20(3):192-6.
34. Ministry of health of Republic of Serbia. National Health Survey Serbia 2006 (in Serbian). [cited 2011 Jul 15]Available from: http://sites.google.com/site/downloadmoh1/FinalniIzvestaj-IstrazivanjeZdravlja.pdf?attredirects=0.
35. Grujić V, Dragnić N, Ukropina S, Nićiforović-Šurković O, Čanković D. Self-perception of being overweight in Serbiaadults. Health Med. 2011;5(2):388-98.
36. August P, Oparil S. Hypertension in women. J Clin Endocrinol Metab. 1999;84:1862-6.
37. Cífková R, Skodová Z, Lánská V, Adámková V, Novozámská E, Jozífová M, et al. Prevalence, awareness, treatment, and controlof hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study. J Hum Hypertens. 2004;18(8):571-9.
38. Dorobantu M, Darabont RO, Badila RO, Ghiorghe S. Prevalence, awareness, treatment, and control of hypertension in Romania: results of the SEPHAR study. Int J Hypertens.2010;970694.
39. Oliveria SA, Chen RS, McCarthy BD, Davis CC, Hill MN. Hypertension knowledge, awareness, and attitudes in a hypertensive population. J Gen Intern Med. 2005;20(3):219-25.
40. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood pressure control in the hypertensive population. Lancet. 1997;349:454-7.
41. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339(27):1957-63.
42. Yoon SS, Ostachega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008.Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2010. NCHS Data Brief no. 48.
43. Hou X. Urban-rural disparity of overweight, hypertension, undiagnosed hypertension, and untreated hypertension in China. Asia Pac J Public Health. 2008;20:159-69.
44. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104(23):2855-64.
45. WHO. Innovative care for chronic conditions: building block for action. Geneva: WHO, document No WHO/MNC/CCH/02.01:2002.